Skip To The Main Content
Section Banner
 

Corporate Partners

OREF funds both investigator-initiated and agenda-driven research. Agenda-driven topics are focused on a specific area of research that is particularly relevant to the field. Within its agenda-driven portfolio, OREF’s Collaborative Research Agenda (CRA) program takes a multi-partner approach to funding research. Through the CRA, OREF brings together researchers, orthopaedic surgeons, industry and other orthopaedic organizations to identify and fund research which addresses current areas of need for basic and translational research.

Current agenda-driven programs (including CRA topics) include:

  • Patient Safety
  • Trauma (CRA)
  • Youth Sports Injuries
  • Hip and Knee Arthoplasty Infection (CRA)
  • Bone Infection
  • Arthritis
  • Stem Cells
Contribute to OREF

For more information about OREF's Corporate Partners program, please contact:

Dan J. Krupp
Vice President, Corporate Relations/Innovation & Partnership Development
(571) 247-1423

Corporate Partners


$100,000 +
The Aircast Foundation
Picture showing logo of Arthrex, Inc., a medical device company

Picture of the logo of Zimmer Biomet, a medical device company


$40,000 +
Medacta USA

$20,000 +
DePuySynthes Logo

$2,500 +
Picture of the logo of Orchid, an orthopaedic device company